Indo Us Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Bio-Tech Limited held its 21st Annual General Meeting on September 30, 2025 via video conferencing, which ran for about 10 minutes (from 2:34 PM to 2:44 PM). Seven resolutions were put to shareholders, including the adoption of audited financial statements for the year ended March 31, 2025, re-appointment of Mrs. Malti Ajudiya as a director by rotation, and re-appointment of Mr. Jagdishkumar Ajudiya as Managing Director. Other resolutions covered an increase in borrowing limits, approval of related party transactions under Section 188 of the Companies Act, and appointment of new internal and secretarial auditors. Voting was conducted through remote e-voting and AGM e-voting facilitated by NSDL, with the scrutinizer required to submit the final voting results within 48 hours. The resolutions are deemed passed if they receive the required majority.
This is a routine regulatory filing confirming the AGM was held as scheduled. No major surprises or material corporate actions beyond standard governance items were disclosed. Shareholders should watch for the scrutinizer's report within 48 hours for final voting outcomes, especially on the borrowing limits and related party transactions which could have a more meaningful impact on the company's capital structure.